Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2166

1.

Measuring NO production rate from l-arginine in MELAS by mass spectrometry-based approaches: GC-MS or LC-MS/MS?

Tsikas D.

Int J Cardiol. 2017 Dec 8. pii: S0167-5273(17)36984-X. doi: 10.1016/j.ijcard.2017.11.040. [Epub ahead of print] No abstract available.

PMID:
29229371
2.

Drug-resistant epilepsy in MELAS: safety and potential efficacy of lacosamide.

Primiano G, Vollono C, Dono F, Servidei S.

Epilepsy Res. 2017 Dec 6;139:135-136. doi: 10.1016/j.eplepsyres.2017.12.001. [Epub ahead of print] No abstract available.

PMID:
29223780
3.

[Study of mitochondrial dysfunction using cytoplasmic hybrid].

Sinyov VV, Sazonova MA, Karagodin VP, Ryzhkova AI, Galitsyna EV, Melnichenko AA, Demakova NA, Shkurat TP, Sobenin IA, Orekhov AN.

Patol Fiziol Eksp Ter. 2017 Apr-Jun;61(2):92-7. Russian.

PMID:
29215849
4.

Focal Segmental Glomerulosclerosis Associated with Chronic Progressive External Ophthalmoplegia and Mitochondrial DNA A3243G Mutation.

Narumi K, Mishima E, Akiyama Y, Matsuhashi T, Nakamichi T, Kisu K, Nishiyama S, Ikenouchi H, Kikuchi A, Izumi R, Miyazaki M, Abe T, Sato H, Ito S.

Nephron. 2017 Nov 30. doi: 10.1159/000485109. [Epub ahead of print]

PMID:
29190634
5.

Cerebral arterial and venous MRI abnormalities in MELAS.

Renard D, Ion I.

Acta Neurol Belg. 2017 Nov 30. doi: 10.1007/s13760-017-0867-7. [Epub ahead of print] No abstract available.

PMID:
29189965
6.

Systemic, intratympanic and combined administration of steroids for sudden hearing loss. A prospective randomized multicenter trial.

Tsounis M, Psillas G, Tsalighopoulos M, Vital V, Maroudias N, Markou K.

Eur Arch Otorhinolaryngol. 2017 Nov 22. doi: 10.1007/s00405-017-4803-5. [Epub ahead of print]

PMID:
29168028
7.

A Mitochondrial Disorder in a Middle Age Iranian Patient: Report of a Rare Case.

Almasi M, Motamed MR, Mehrpour M, Haghi-Ashtiani B, Haji Akhondi F, Nilipour Y, Fereshtehnejad SM.

Basic Clin Neurosci. 2017 Jul-Aug;8(4):337-341. doi: 10.18869/nirp.bcn.8.4.337.

8.

Gastro-intestinal Involvement in m.3243A>G-associated Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like Episodes.

Suzuki J, Iwata M, Moriyoshi H, Nishida S, Yasuda T, Ito Y.

Intern Med. 2017 Nov 20. doi: 10.2169/internalmedicine.9632-17. [Epub ahead of print] No abstract available.

9.

Gastrointestinal Involvement in m.3243A>G-associated MELAS.

Finsterer J, Zarrouk-Mahjoub S.

Intern Med. 2017 Nov 20. doi: 10.2169/internalmedicine.9439-17. [Epub ahead of print] No abstract available.

10.

The art of oral handovers: a participant observational study by undergraduate students in a hospital setting.

Giske T, MelÄs SN, Einarsen KA.

J Clin Nurs. 2017 Nov 17. doi: 10.1111/jocn.14177. [Epub ahead of print]

PMID:
29148607
11.

Prevalence of Headache in Patients With Mitochondrial Disease: A Cross-Sectional Study.

Kraya T, Deschauer M, Joshi PR, Zierz S, Gaul C.

Headache. 2017 Nov 15. doi: 10.1111/head.13219. [Epub ahead of print]

PMID:
29139113
12.

TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation.

Yahata N, Matsumoto Y, Omi M, Yamamoto N, Hata R.

Sci Rep. 2017 Nov 14;7(1):15557. doi: 10.1038/s41598-017-15871-y.

13.

Brain volume in early MS patients with and without IgG oligoclonal bands in CSF.

Fenu G, Lorefice L, Sechi V, Loi L, Contu F, Cabras F, Coghe G, Frau J, Secci MA, Melis C, Schirru L, Costa G, Melas V, Arru M, Barracciu MA, Marrosu MG, Cocco E.

Mult Scler Relat Disord. 2017 Nov 8;19:55-58. doi: 10.1016/j.msard.2017.11.005. [Epub ahead of print]

PMID:
29132035
14.

Avascular necrosis after long-term glucocorticoid treatment in MELAS: a cautionary note.

Choi HS, Lee JH, Lee SH, Lee YM.

J Inherit Metab Dis. 2017 Nov 6. doi: 10.1007/s10545-017-0110-y. [Epub ahead of print] No abstract available.

PMID:
29110176
15.

Prior alcohol use enhances vulnerability to compulsive cocaine self-administration by promoting degradation of HDAC4 and HDAC5.

Griffin EA Jr, Melas PA, Zhou R, Li Y, Mercado P, Kempadoo KA, Stephenson S, Colnaghi L, Taylor K, Hu MC, Kandel ER, Kandel DB.

Sci Adv. 2017 Nov 1;3(11):e1701682. doi: 10.1126/sciadv.1701682. eCollection 2017 Nov.

16.

Inflexibility of AMPK-mediated metabolic reprogramming in mitochondrial disease.

Lin DS, Kao SH, Ho CS, Wei YH, Hung PL, Hsu MH, Wu TY, Wang TJ, Jian YR, Lee TH, Chiang MF.

Oncotarget. 2017 Sep 1;8(43):73627-73639. doi: 10.18632/oncotarget.20617. eCollection 2017 Sep 26.

17.

Mitochondrial DNA density homeostasis accounts for a threshold effect in a cybrid model of a human mitochondrial disease.

Aryaman J, Johnston IG, Jones NS.

Biochem J. 2017 Nov 24;474(23):4019-4034. doi: 10.1042/BCJ20170651.

PMID:
29079678
18.

Advances in omics for informed pharmaceutical research and development in the era of systems medicine.

Bai JPF, Melas IN, Hur J, Guo E.

Expert Opin Drug Discov. 2018 Jan;13(1):1-4. doi: 10.1080/17460441.2018.1394839. Epub 2017 Oct 27. No abstract available.

PMID:
29073782
19.

High diving metabolic rate indicated by high-speed transit to depth in negatively buoyant long-finned pilot whales.

Aoki K, Sato K, Isojunno S, Narazaki T, Miller PJO.

J Exp Biol. 2017 Oct 15;220(Pt 20):3802-3811. doi: 10.1242/jeb.158287.

PMID:
29046419
20.

Focal segmental glomerulosclerosis associated with mitochondrial disease.

Lim K, Steele D, Fenves A, Thadhani R, Heher E, Karaa A.

Clin Nephrol Case Stud. 2017 Mar 3;5:20-25. doi: 10.5414/CNCS109083. eCollection 2017.

Supplemental Content

Loading ...
Support Center